Barrington Research Maintains Outperform on Orthofix Medical, Raises Price Target to $18
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price target from $17 to $18.
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price target from $17 to $18.